Accumulation of glucose in keloids with FDG-PET

Annals of Nuclear Medicine

Volumn 20, Issue 1, 2006, Pages 41-44

  Ozawa, Toshiyuki ^a   Okamura, Terue ^a   Harada, Teruichi ^a   Muraoka, Michinari ^a   Ozawa, Nozomi ^a   Koyama, Koichi ^a   Inoue, Yuichi ^a   Ishii, Masamitsu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

FDG PET; Glucose metabolism; Keloids

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ARTICLE; CALCULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TISSUE LEVEL; DRUG UPTAKE; FEMALE; GLUCOSE METABOLISM; HUMAN; KELOID; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCANNING TRANSMISSION ELECTRON MICROSCOPY; STANDARD;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HUMANS; KELOID; MALE; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 33644825339     PISSN: 09147187     EISSN: 09147187     Source Type: Journal    
DOI: 10.1007/BF02985589     Document Type: Article

References (11)

1. Murray JC. Keloids and hypertrophic scars. Clin Dermatol 1994; 12: 27-37.
2. Tuan TL, Nichter LS. The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 1998; 4: 19-24.
3. Niessen FB, Spauwen PH, Schalkwijk J, Kon M. On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 1999; 104: 1435-1458.
4. Kubota K. From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 2001; 15: 471-486.
5. 18F-fluorodeoxyglucose-positron emission tomography: a new explorative perspective. Exp Gerontol 2003; 38: 463-470.
6. Otsuka H, Graham M, Kubo A, Nishitani H. Clinical utility of FDG PET. J Med Invest 2004; 51: 14-19.
7. Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18- fluorodeoxyglucose uptake. J Nucl Med 1994; 35: 104-112.
8. Ueda K, Furuya E, Yasuda Y, Oba S, Tajima S. Keloids have continuous high metabolic activity. Plast Reconstr Surg 1999; 104: 694-698.
9. Shetlar MR, Dobrkovsky M, Linares H, Villarante R, Shetlar CL, Larson DL. The hypertrophic scar. Glycoprotein and collagen components of burn scars. Proc Soc Exp Biol Med 1971; 138: 298-300.
10. Kischer CW, Hendrix MJ. Fibronectin (FN) in hypertrophic scars and keloids. Cell Tissue Res 1983; 231: 29-37.
11. Kischer CW, Wagner HN Jr, Pindur J, Holubec H, Jones M, Ulreich JB, et al. Increased fibronectin production by cell lines from hypertrophic scar and keloid. Connect Tissue Res 1989; 23: 279-288.